Allergan PLC Company Profile (NYSE:AGN)

About Allergan PLC

Allergan PLC logoAllergan, Inc. is a multi-specialty healthcare company. The Company focuses on developing and commercializing pharmaceuticals, biologics, medical devices and over-the-counter (OTC) products. It discovers, develops and commercializes a range of products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, urological and other specialty markets. The Company operates in two segments: specialty pharmaceuticals and medical devices. The specialty pharmaceuticals segment produces products, including ophthalmic products for dry eye, glaucoma, inflammation, infection, allergy and retinal disease; Botox for therapeutic and aesthetic indications; skin care products for acne, psoriasis, eyelash growth and prescription and OTC skin care products, and urologics products. The medical devices segment produces medical devices, including breast implants for augmentation, revision and reconstructive surgery and tissue expanders, and facial aesthetics products.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: Pharmaceuticals
  • Exchange: NYSE
  • Symbol: AGN
  • CUSIP: 01849010
Key Metrics:
  • Previous Close: $253.21
  • 50 Day Moving Average: $248.5240
  • 200 Day Moving Average: $249.1810
  • Trailing P/E Ratio: 23.3734
  • Foreward P/E Ratio: 14.39
  • P/E Growth: 1.3400
  • Market Cap: $97.20B
  • Outstanding Shares: 395,952,000
  • Beta: 0.7
Additional Links:
Companies Related to Allergan PLC:

Analyst Ratings

Consensus Ratings for Allergan PLC (NYSE:AGN) (?)
Ratings Breakdown: 4 Hold Ratings, 17 Buy Ratings
Consensus Rating:Buy (Score: 2.81)
Consensus Price Target: $311.90 (28.21% upside)

Analysts' Ratings History for Allergan PLC (NYSE:AGN)
DateFirmActionRatingPrice TargetDetails
8/19/2016MizuhoUpgradeNeutral -> Buy$248.00 -> $318.00View Rating Details
8/10/2016RBC Capital MarketsReiterated RatingOutperform$307.00 -> $300.00View Rating Details
8/8/2016Leerink SwannSet Price TargetBuy$294.00View Rating Details
8/9/2016Piper Jaffray Cos.Set Price TargetHold$236.00 -> $227.00View Rating Details
8/9/2016Deutsche Bank AGLower Price TargetBuy$282.00 -> $278.00View Rating Details
8/9/2016Royal Bank Of CanadaLower Price TargetOutperform$307.00 -> $300.00View Rating Details
8/5/2016JPMorgan Chase & Co.Set Price TargetBuy$325.00View Rating Details
8/3/2016Credit Suisse Group AGSet Price TargetHold$322.00View Rating Details
7/6/2016Goldman Sachs Group Inc.Reiterated RatingBuyView Rating Details
6/29/2016Morgan StanleyReiterated RatingOverweightView Rating Details
6/29/2016Bank of America Corp.Reiterated RatingBuy$287.00 -> $294.00View Rating Details
6/10/2016Wells Fargo & Co.Reiterated RatingBuyView Rating Details
6/9/2016Sanford C. BernsteinReiterated RatingOutperform$335.00View Rating Details
5/29/2016Citigroup Inc.Reiterated RatingBuyView Rating Details
5/24/2016Cowen and CompanyReiterated RatingBuyView Rating Details
4/18/2016GuggenheimInitiated CoverageNeutralView Rating Details
4/12/2016S&P Equity ResearchReiterated RatingBuyView Rating Details
4/7/2016Raymond James Financial Inc.Lower Price TargetOutperform$317.00 -> $275.00View Rating Details
4/7/2016Canaccord GenuityReiterated RatingBuyView Rating Details
4/7/2016SusquehannaDowngradePositive -> Neutral$345.00 -> $275.00View Rating Details
4/5/2016NomuraReiterated RatingBuy$350.00 -> $330.00View Rating Details
7/29/2015Barclays PLCReiterated RatingHoldView Rating Details
6/20/2015BMO Capital MarketsSet Price TargetBuy$378.00View Rating Details
1/8/2015BTIG ResearchDowngradeBuy -> NeutralView Rating Details
12/15/2014Stifel NicolausDowngradeBuy -> Hold$200.00View Rating Details
11/18/2014Jefferies GroupReiterated RatingHold$184.00 -> $219.00View Rating Details
11/18/2014SunTrust Banks Inc.DowngradeBuy -> NeutralView Rating Details
11/18/2014William BlairDowngradeOutperform -> Market Perform$219.00View Rating Details
9/4/2014Evercore ISIInitiated CoverageBuyView Rating Details
(Data available from 8/25/2014 forward)


Earnings History for Allergan PLC (NYSE:AGN)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/8/2016Q216$3.34$3.35$4.10 billion$3.68 billionViewListenView Earnings Details
5/10/2016Q116$3.03$3.04$3.97 billion$3.80 billionViewListenView Earnings Details
2/22/2016Q415$3.36$3.41$4.20 billion$4.20 billionViewListenView Earnings Details
11/4/2015Q315$3.18$3.48$5.71 billion$4.10 billionViewN/AView Earnings Details
8/6/2015Q215$4.38$4.41$5.71 billion$5.76 billionViewN/AView Earnings Details
2/4/2015Q414$1.83$2.17$1.90 billion$1.91 billionViewN/AView Earnings Details
10/27/2014Q314$1.68$1.78$1.78 billion$1.79 billionViewListenView Earnings Details
7/21/2014Q214$1.44$1.51$1.77 billion$1.83 billionViewN/AView Earnings Details
5/7/2014Q114$1.13$1.18$1.60 billion$1.65 billionViewN/AView Earnings Details
2/4/2014Q413$1.34$1.12$1.65 million$1.66 millionViewN/AView Earnings Details
10/29/2013Q313$1.20$1.23$1.53 billion$1.23 billionViewListenView Earnings Details
7/31/2013Q2 2013$1.20$1.22$1.56 billion$1.60 billionViewN/AView Earnings Details
5/1/2013Q1 2013$0.96$0.98$1.44 billion$1.46 billionViewN/AView Earnings Details
2/5/2013Q4 2012$1.20$1.15$1.51 million$1.48 millionViewN/AView Earnings Details
10/30/2012Q312$1.04$1.06$1.43 billion$1.39 billionViewN/AView Earnings Details
8/1/2012$1.06$1.07ViewN/AView Earnings Details
5/2/2012$0.87$0.86ViewN/AView Earnings Details
2/2/2012$1.00$1.00ViewN/AView Earnings Details
10/26/2011$0.90$0.92ViewN/AView Earnings Details
8/3/2011$0.95$0.96ViewN/AView Earnings Details
5/4/2011$0.74$0.77ViewN/AView Earnings Details
2/2/2011$0.89$0.88ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Allergan PLC (NYSE:AGN)
Current Year EPS Consensus Estimate: $13.98 EPS
Next Year EPS Consensus Estimate: $16.9 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$2.91$3.17$3.04
Q2 20161$3.29$3.29$3.29
Q3 20161$3.57$3.57$3.57
Q4 20161$4.14$4.14$4.14
(Data provided by Zacks Investment Research)


Current Dividend Information for Allergan PLC (NYSE:AGN)
Annual Dividend:$0.00
Dividend Yield:0.00%
Payout Ratio:0.00% (Based on Trailing 12 Months of Earnings)
0.00% (Based on Current Year Consensus EPS Estimate)
0.00% (Based on Next Year Consensus EPS Estimate)
Dividend Growth:-37.00% (3 Year Average)

Dividend History for Allergan PLC (NYSE:AGN)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Allergan PLC (NYSE:AGN)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
6/2/2016Maria Teresa HiladoCFOBuy661$241.57$159,677.77View SEC Filing  
5/11/2016Nesli BasgozDirectorSell459$225.10$103,320.90View SEC Filing  
12/7/2015Nesli BasgozDirectorSell2,300$312.96$719,808.00View SEC Filing  
8/24/2015Paul BisaroChairmanBuy1,000$297.42$297,420.00View SEC Filing  
8/21/2015Brent L SaundersCEOBuy1,000$301.94$301,940.00View SEC Filing  
4/22/2014Scott ShermanEVPSell14,500$155.82$2,259,390.00View SEC Filing  
2/21/2014Louis Lavigne, Jr.DirectorSell5,400$125.79$679,266.00View SEC Filing  
2/19/2014Dawn HudsonDirectorSell4,200$126.35$530,670.00View SEC Filing  
2/19/2014Jeffrey EdwardsCFOSell38,900$126.39$4,916,571.00View SEC Filing  
2/19/2014Raymond DiradoorianEVPSell23,000$126.66$2,913,180.00View SEC Filing  
2/18/2014Scott ShermanEVPSell5,001$125.74$628,825.74View SEC Filing  
1/14/2014Scott WhitcupVPSell42,000$117.80$4,947,600.00View SEC Filing  
12/27/2013Julian GangolliVPSell52,500$110.05$5,777,625.00View SEC Filing  
12/20/2013Scott WhitcupVPSell33,000$108.80$3,590,400.00View SEC Filing  
10/15/2013Trevor JonesDirectorSell2,000$90.14$180,280.00View SEC Filing  
9/16/2013Trevor JonesDirectorSell2,000$89.78$179,560.00View SEC Filing  
8/15/2013Trevor JonesDirectorSell2,000$89.89$179,780.00View SEC Filing  
8/6/2013Jeffrey EdwardsCFOSell69,200$91.17$6,308,964.00View SEC Filing  
7/15/2013Trevor M JonesDirectorSell2,000$91.15$182,300.00View SEC Filing  
6/17/2013Trevor M JonesDirectorSell2,000$101.25$202,500.00View SEC Filing  
5/15/2013Trevor M JonesDirectorSell2,000$103.40$206,800.00View SEC Filing  
5/9/2013Jeffrey L EdwardsCFOSell84,000$103.49$8,693,160.00View SEC Filing  
11/26/2012Trevor M JonesDirectorSell2,500$91.30$228,250.00View SEC Filing  
10/5/2012David E I PyottCEOSell616,300$93.73$57,765,799.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Allergan PLC (NYSE:AGN)
DateHeadline logoTop 5 Shareholders of Allergan (AGN) (NYSE:AGN) - August 24 at 3:22 PM logoTop 5 Shareholders of Allergan (AGN) (NYSE:AGN) - August 24 at 3:22 PM
News IconAllergan plc (NYSE:AGN) from Drugs – Generic – Todays Top Gains (NYSE:AGN) - August 24 at 3:22 PM
News IconAllergan plc (NYSE:AGN) from Drugs – Generic – Todays Top Gains (NYSE:AGN) - August 24 at 3:22 PM logoPfizer on buying spree with AstraZeneca antibiotics deal (NYSE:AGN) - August 24 at 3:22 PM logoPfizer on buying spree with AstraZeneca antibiotics deal (NYSE:AGN) - August 24 at 3:22 PM
News IconAnalysts Valuations For Two Stocks: CBRE Group Inc (NYSE:CBG), Allergan plc Ordinary Shares (NYSE:AGN) - The Voice Registrar (NYSE:AGN) - August 24 at 11:41 AM logoDavid Einhorn Cashed Out of These 9 Stocks (NYSE:AGN) - August 24 at 11:40 AM logoPerformance of AstraZeneca’s RI&A Segment in 2Q16 (NYSE:AGN) - August 24 at 11:40 AM logoAllergan Makes an Eye-Opening Acquisition (NYSE:AGN) - August 22 at 10:16 AM logoPfizer Pays a Big Premium for Medivation (NYSE:AGN) - August 22 at 8:09 AM logoAllergan plc Ordinary Shares (AGN) Upgraded At Mizuho Securities On Lower Risk - TCC (NYSE:AGN) - August 19 at 4:01 PM logoAllergan Upgraded As New Product Launch Could Drive Botox Sales (NYSE:AGN) - August 19 at 4:01 PM logoNoteworthy Friday Option Activity: AGN, SLB, BIIB (NYSE:AGN) - August 19 at 1:57 PM
News IconLiberty Interactive Corp (NASDAQ:QVCA) & Allergan plc Ordinary Shares (NYSE:AGN) Trend Analysis Report - Money News (press release) (NYSE:AGN) - August 19 at 11:47 AM logoTop stocks for hedge funds (NYSE:AGN) - August 19 at 11:47 AM logoAllergan Plc (NYSE:AGN) Investigates Kybella As Remedy For Bra-Line Fat - Market Exclusive (NYSE:AGN) - August 17 at 3:24 PM
News IconAnalysts Concerns on: Allergan plc Ordinary Shares (NYSE:AGN) - Post Registrar (NYSE:AGN) - August 17 at 3:24 PM
News IconLarge Cap Drugs – Generic: Allergan plc (NYSE:AGN) (NYSE:AGN) - August 17 at 11:37 AM logoCredit Suisse Presents Bull And Bear Cases For Allergan (NYSE:AGN) - August 16 at 8:41 PM
News IconTop Gainers of the Day: Allergan plc (NYSE:AGN) from Drugs – Generic (NYSE:AGN) - August 16 at 8:41 PM
News IconThe Key Numbers To Watch From Allergan plc (AGN)'s Earnings - The Voice Registrar (NYSE:AGN) - August 16 at 11:58 AM logoWhy is Time (TIME) Stock Popping Today? (NYSE:AGN) - August 15 at 3:24 PM
News IconUpdate on Allergan plc (NYSE:AGN) for the day (NYSE:AGN) - August 13 at 11:31 AM
News IconHot Line At Active Movers- Allergan plc (NYSE:AGN), Fusion Telecommunications (NASDAQ:FSNN), Ingram Micro ... - Seneca Globe (NYSE:AGN) - August 12 at 3:33 PM logoAllergan plc Ordinary Shares's (AGN) Brent Saunders Moving Ahead with M&A Policy - TCC (NYSE:AGN) - August 12 at 3:33 PM logoAllergan plc Ordinary Shares's (AGN) Brent Saunders Moving Ahead with M&A Policy (NYSE:AGN) - August 12 at 11:57 AM logoAllergan buys eye care firm ForSight VISION5 - Seeking Alpha (NYSE:AGN) - August 11 at 3:26 PM
News IconAllergan plc (NYSE:AGN) – Top Stock from Healthcare Sector – The ... - The Daily Leicester (NYSE:AGN) - August 11 at 3:26 PM logoETF’s with exposure to Allergan Plc : August 11, 2016 (NYSE:AGN) - August 11 at 12:37 PM logoAllergan buys eye care firm ForSight VISION5 (NYSE:AGN) - August 11 at 9:55 AM logoBRIEF-Allergan to acquire eye care company Forsight Vision5 (NYSE:AGN) - August 11 at 8:35 AM logoEye Catching Stocks: Allergan plc (AGN), Gramercy Property Trust Inc. (GPT), Integrated Device Technology, Inc. (IDTI) - iStreetWire (NYSE:AGN) - August 10 at 3:44 PM
News IconRegulus Therapeutics Inc (RGLS), Allergan plc Ordinary Shares (AGN) - share market updates (press release) (NYSE:AGN) - August 10 at 12:51 PM logoAllergan plc Ordinary Shares (AGN) Rebuffed to Acquire Biogen Inc (BIIB) - TCC (NYSE:AGN) - August 10 at 12:51 PM logoAllergan Plc :AGN-US: Earnings Analysis: Q2, 2016 By the Numbers : August 10, 2016 (NYSE:AGN) - August 10 at 12:51 PM logoPfizer’s Business Segments and Their Performance (NYSE:AGN) - August 10 at 12:51 PM logoEarnings Whispers: Allergan plc Ordinary Shares (AGN) and Horizon Pharma PLC (HZNP) (NYSE:AGN) - August 9 at 4:11 PM
News IconIs Allergan plc (NYSE:AGN), a large market cap stock a smart buy? (NYSE:AGN) - August 9 at 4:11 PM logoAllergan focused on 'stepping stone' deals, not big ones like Biogen (NYSE:AGN) - August 9 at 4:11 PM logoAllergan Mandatory Convertible Preferred Shares, Series A About To Put More Money In Your Pocket (NYSE:AGN) - August 9 at 4:11 PM
News IconAnalyst Ratings Outlook on Allergan plc Ordinary (AGN) - The Voice Registrar (NYSE:AGN) - August 9 at 12:08 PM logoWhy Allergan May Be In Trouble - Seeking Alpha (NYSE:AGN) - August 9 at 12:08 PM
News IconCalifornia Resources (NYSE:CRC) & Allergan plc Ordinary Shares (NYSE:AGN) Active Movers - Money News (press release) (NYSE:AGN) - August 9 at 12:08 PM logoAllergan revenues up 2%; updates guidance - Seeking Alpha (NYSE:AGN) - August 8 at 8:50 PM
News IconScientific Games Corp (NASDAQ:SGMS) & Allergan plc Ordinary Shares (NYSE:AGN) Active Movers - Money News (press release) (NYSE:AGN) - August 8 at 3:23 PM logoEarnings Whispers: Allergan plc Ordinary Shares (AGN) and Horizon Pharma PLC (HZNP) - TCC (NYSE:AGN) - August 8 at 3:23 PM logoAllergan Plc (AGN) Brenton L. Saunders on Q2 2016 Results - Earnings Call Transcript - Seeking Alpha (NYSE:AGN) - August 8 at 3:23 PM logoUPDATE 3-Allergan focused on 'stepping stone' deals, not big ones like Biogen (NYSE:AGN) - August 8 at 1:58 PM logoAllergan falls 3% after revenue disappoints, as Alzheimer drug loses exclusivity (NYSE:AGN) - August 8 at 11:07 AM


Allergan PLC (NYSE:AGN) Chart for Thursday, August, 25, 2016

Last Updated on 8/25/2016 by Staff